Niagen®

DIETARY_SUPPLEMENT3 trials

Sponsors

University of Delaware, Nutraceuticals Research Institute, Massachusetts General Hospital

Conditions

Healthy AdultHealthy AgingMild Cognitive Impairment

Phase 1

NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

CompletedNCT03482167

University of DelawareMild Cognitive Impairment

Start: 2019-03-20End: 2024-01-22Updated: 2025-04-04

Unknown Phase

Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+

RecruitingNCT06919328

Nutraceuticals Research InstituteHealthy Aging

Start: 2024-10-31End: 2025-06-30Target: 70Updated: 2025-04-09

Nicotinamide Riboside, Vit B3 Analogue, and Brain Energy Metabolism

RecruitingNCT07649161

Massachusetts General HospitalHealthy Adult

Start: 2026-06-01End: 2028-01-01Target: 50Updated: 2026-06-17